The donations laid the cornerstone and financed the first building on January 25, 1858
The product type segment includes semaglutide, liraglutide, exenatide, dulaglutide, and others, with semaglutide leading the market in 2024, accounting for 58.4% of total share
Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase
Its antioxidant properties help neutralise free radicals that accelerate visible aging, while its ability to upregulate growth factors supports the natural healing cycle of aging or stressed skin
The decision follows the identification of a case of potential drug-induced liver injury in a recent clinical trial participant, despite the compound showing promising pharmacokinetic profiles in dose-optimisation studies